Q-Cells SE increases share in Solibro GmbH to 100%

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------

Bitterfeld-Wolfen, 26 June 2009 - Q-Cells SE (QCE; ISIN DE0005558662)
increases its interest in Solibro GmbH from previously 67.5% to 100%
by acquiring the Swedish joint venture partner Solibro AB. Solibro's
modules rank among those with the highest efficiency rating in the
field of thin-film technologies. At present, Solibro's modules
achieve an average efficiency rating per module of around 10%; the
peak values are in excess of 11%.

"The potential of Solibro's thin-film modules lies in the combination
of high efficiency ratings with extremely low costs per watt. After
we successfully implemented this potential in mass production as
well, Solibro became an integral component of Q-Cells' thin-film
strategy," said Dr. Florian Holzapfel, member of the Executive Board
of Q-Cells SE and Head of the New Technologies division. "Taking this
step is a sign of our confidence in the technology. This way, we have
the degree of freedom we need to develop Solibro into a leading
global provider of thin-film technologies," added Dr. Johannes
Segner, COO and Managing Director of Solibro GmbH.

Solibro GmbH was formed by Q-Cells and Solibro AB at the end of 2006
to commercialise a CIGS thin-film technology developed at the
University of Uppsala. The first test modules were created on the
production line in Saxony-Anhalt's Solar Valley as early as spring
2008. Mass production began in the third quarter of 2008. The
foundations for a second production line were laid in Thalheim at the
end of last year. It is expected to commence production in the fourth
quarter of this year and achieve full capacity of 90 MWp after about
twelve months with a module efficiency rating of around 12%.

The acquisition is being implemented as a capital increase against
non-cash contributions. In return for their shares in Solibro GmbH,
the shareholders of Solibro AB, amongst others the pension fund "6th
Swedish National Pension Fund", will receive 3,988,170 shares in
Q-Cells SE. 50% of these shares are subject to a lock-up period of at
least 180 days. As a result, Solibro GmbH will now become a fully
consolidated, wholly owned subsidiary of Q-Cells SE rather than an
investment carried at equity.

Contact information:
Q-Cells SE
OT Thalheim
Sonnenallee 17 - 21
06766 Bitterfeld-Wolfen, Germany
www.q-cells.com

Investor Relations:
Stefan Lissner
Phone: +49 - (0)3494 - 6699 10101
investor@q-cells.com

Public Relations:
Markus Wieser
Phone: +49 - (0)3494 - 6699 10111
presse@q-cells.com

--- End of Message ---

Q-Cells SE
OT Thalheim, Sonnenallee 17-21 Bitterfeld-Wolfen
Germany

WKN: 555866; ISIN: DE0005558662; Index: CDAX, GEX, Prime All Share,
TecDAX;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in
Bayerische Börse München,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Börse Stuttgart,
Regulierter Markt in Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2009. All rights reserved.